» Articles » PMID: 22021213

Substructure-based Virtual Screening for Adenosine A2A Receptor Ligands

Overview
Journal ChemMedChem
Specialties Chemistry
Pharmacology
Date 2011 Oct 25
PMID 22021213
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

A virtual ligand-based screening approach was designed and evaluated for the discovery of new A(2A) adenosine receptor (AR) ligands. For comparison and evaluation, the procedures from a recently published virtual screening study that used the A(2A) AR X-ray crystal structure for the target-based discovery of new A(2A) ligands were largely followed. Several screening models were constructed by deriving the distinguishing structural features from selected sets of A(2A) AR antagonists, so-called frequent substructure mining. The best model in statistical terms was subsequently applied to large-scale virtual screens of a commercial vendor library. This resulted in the selection of 36 candidates for acquisition and testing. Of the selected candidates, eight compounds significantly inhibited radioligand binding at A(2A) AR (>30%) at 10 μM, corresponding to a "hit rate" of 22%. This hit rate is quite similar to that of the referenced target-based virtual screening study, while both approaches yield new, non-overlapping sets of ligands.

Citing Articles

AI-based identification of therapeutic agents targeting GPCRs: introducing ligand type classifiers and systems biology.

Gossen J, Ribeiro R, Bier D, Neumaier B, Carloni P, Giorgetti A Chem Sci. 2023; 14(32):8651-8661.

PMID: 37592985 PMC: 10430665. DOI: 10.1039/d3sc02352d.


Structural and energetic effects of A2A adenosine receptor mutations on agonist and antagonist binding.

Keranen H, Gutierrez-de-Teran H, Aqvist J PLoS One. 2014; 9(10):e108492.

PMID: 25285959 PMC: 4186821. DOI: 10.1371/journal.pone.0108492.


Hierarchical virtual screening approaches in small molecule drug discovery.

Kumar A, Zhang K Methods. 2014; 71:26-37.

PMID: 25072167 PMC: 7129923. DOI: 10.1016/j.ymeth.2014.07.007.


Crystal structures of the A adenosine receptor and their use in medicinal chemistry.

Jacobson K In Silico Pharmacol. 2014; 1:22.

PMID: 24660138 PMC: 3956660. DOI: 10.1186/2193-9616-1-22.


Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates.

Jacobson K J Med Chem. 2013; 56(10):3749-67.

PMID: 23597047 PMC: 3701956. DOI: 10.1021/jm400422s.